Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-26-249726
Filing Date
2026-06-01
Accepted
2026-06-01 07:30:11
Documents
2

Document Format Files

Seq Description Document Type Size
1 DEFA14A d71098ddefa14a.htm DEFA14A 17436
2 GRAPHIC g71098g0531201631859.jpg GRAPHIC 6695
  Complete submission text file 0001193125-26-249726.txt   27867
Mailing Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104
Business Address 2929 ARCH STREET SUITE 600 PHILADELPHIA PA 19104 (267) 759-3100
Cabaletta Bio, Inc. (Filer) CIK: 0001759138 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-39103 | Film No.: 261047168
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)